ReviewInfection2022
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe.
Review in Infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 95 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
95 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The Effectiveness of Online Exercise on Physical Activity, Motor Function, and Mental Health: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2025Pooled it
- Endotheliopathy in Acute COVID-19 and Long COVID.International journal of molecular sciences · 2023Pooled it
- Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis.Viruses · 2023Pooled it
- Host genotype and sex shape influenza evolution and defective viral genomes.Nature communications · 2026Article
- Genomic surveillance of SARS-CoV-2 variants in hospitalized patients: a cohort study from the metropolitan area of valle de Aburrá, ColombiaBiomedica : revista del Instituto Nacional de Salud · 2026Article
- Translational MicroRNA research in COVID-19: bridging in Silico prediction with clinical biomarker potential.Clinical and experimental medicine · 2026Article
- Modeling and Characterizing the Growth of the Texas-New Mexico Measles Outbreak of 2025.Epidemiologia (Basel, Switzerland) · 2025Article
- Mathematical models to characterize the early phase of the COVID-19 pandemic in New Mexico, USA.Mathematical biosciences and engineering : MBE · 2025Article
- Impact of ceiling of care on mortality across four COVID-19 epidemic waves in Catalonia: a multicentre prospective cohort study.BMJ open · 2025Article
- Persistent mortality in critical COVID-19 ICU cases from wild-type to delta variant: A descriptive cohort study.Scientific reports · 2025Observational
- Factors predictive of epidemic waves of COVID-19 in Africa during the first 2 years of the pandemic.IJID regions · 2025Article
- Excess mortality in older adults and cumulative excess mortality across all ages during the COVID-19 pandemic in the 20 countries with the highest mortality rates worldwide.Osong public health and research perspectives · 2025Article
- Circulation and Genetic Characterizations of Coronaviruses From Companion Animals in Chengdu, Southwest China: One-Year Postpandemic.Transboundary and emerging diseases · 2025Article
- Assessing the utility of the COVID-19 epidemic Situations of Concern classification system in guiding operational responses to the pandemic in the WHO African region: retrospective analysis.Frontiers in public health · 2025Review
- The immunological impact of revaccination in a hybrid-immune world.Frontiers in immunology · 2025Review
- Article
- Singapore's COVID-19 Genomic Surveillance Programme: Strategies and Insights From a Pandemic Year.Influenza and other respiratory viruses · 2024Article
- Comparative analysis of COVID-19-associated venous thromboembolism outcomes: evolution from 2020 to 2021-2022.Journal of thrombosis and thrombolysis · 2024Article
- Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders.bioRxiv : the preprint server for biology · 2024Article
- Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders.Briefings in bioinformatics · 2024Article
35 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease-19 has left a permanent mark on the history of the human race. Severe acute respiratory syndrome coronavirus-2 is a positive-sense single-stranded RNA virus, first reported in Wuhan, China, in December 2019 and from there took over the world. Being highly susceptible to mutations, the virus's numerous variants started to appear, and some were more lethal and infectious than the parent. The effectiveness of the vaccine is also affected severely against the new variant. In this study, the infectious mechanism of the coronavirus is explained with a focus on different variants and their respective mutations, which play a critical role in the increased transmissibility, infectivity, and immune escape of the virus. As India has already faced the second wave of the pandemic, the future outlook on the likeliness of a third wave with respect to the Indian variants such as kappa, delta, and Delta Plus is also discussed. This review article aims to reflect the catastrophe of the variants of SARS-CoV-2 and the possibility of developing even more severe variants in the near future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.